CapitalBio to Use Affy's 500K Arrays for Genotyping Service in China | GenomeWeb
NEW YORK (GenomeWeb News) - CapitalBio will offer genotyping services using Affymetrix's GeneChip human mapping 500K array set, the company said today.
 
CapitalBio is a certified Affymetrix Service Provider and has used Affy's array technology as part of its existing services in China for more than a year. The company has also collaborated on joint R&D and commercialization programs with Affymetrix.
 
Additional details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.